7R8N
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
Summary for 7R8N
Entry DOI | 10.2210/pdb7r8n/pdb |
EMDB information | 24319 |
Descriptor | Spike glycoprotein, C051 Fab Heavy Chain, C051 Fab Light Chain, ... (5 entities in total) |
Functional Keywords | sars-cov-2, receptor binding domain, rbd, neutralizing antibody, covid-19, spike, antiviral protein, viral protein-immune system complex, viral protein/immune system |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2) More |
Total number of polymer chains | 9 |
Total formula weight | 575995.46 |
Authors | Barnes, C.O.,Bjorkman, P.J. (deposition date: 2021-06-26, release date: 2021-08-04, Last modification date: 2021-10-06) |
Primary citation | Muecksch, F.,Weisblum, Y.,Barnes, C.O.,Schmidt, F.,Schaefer-Babajew, D.,Wang, Z.,C Lorenzi, J.C.,Flyak, A.I.,DeLaitsch, A.T.,Huey-Tubman, K.E.,Hou, S.,Schiffer, C.A.,Gaebler, C.,Da Silva, J.,Poston, D.,Finkin, S.,Cho, A.,Cipolla, M.,Oliveira, T.Y.,Millard, K.G.,Ramos, V.,Gazumyan, A.,Rutkowska, M.,Caskey, M.,Nussenzweig, M.C.,Bjorkman, P.J.,Hatziioannou, T.,Bieniasz, P.D. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity, 54:1853-1868.e7, 2021 Cited by PubMed: 34331873DOI: 10.1016/j.immuni.2021.07.008 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.55 Å) |
Structure validation
Download full validation report